Similar articles

• Disruption of the STAT4 signaling pathway protects from autoimmune diabetes while retaining antiviral immune competence.

  Holz A, Bot A, Coon B, Wolfe T, Grusby MJ, von Herrath MG. Holz A, et al. J Immunol. 1999 Nov 15;163(10):5374-82. J Immunol. 1999. PMID: 10553062
• Effect of targeted disruption of signal transducer and activator of transcription (Stat)4 and Stat6 genes on the autoimmune diabetes development induced by multiple low doses of streptozotocin.

  Cetkovic-Cvrlje M, Uckun FM. Cetkovic-Cvrlje M, et al. Clin Immunol. 2005 Mar;114(3):299-306. doi: 10.1016/j.clim.2004.11.001. Clin Immunol. 2005. PMID: 15721841
• The biology of Stat4 and Stat6.

  Wurster AL, Tanaka T, Grusby MJ. Wurster AL, et al. Oncogene. 2000 May 15;19(21):2577-84. doi: 10.1038/sj.onc.1203485. Oncogene. 2000. PMID: 10851056 Review.
• [Transgenic mouse model of type 1 diabetes mellitus].

  Hosoda K, Son C, Fujikura J, Iwakura H, Tomita T, Nakao K. Hosoda K, et al. Nihon Rinsho. 2002 Aug;60 Suppl 8:70-4. Nihon Rinsho. 2002. PMID: 12355837 Review. Japanese. No abstract available.
• Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury.

  Yokota N, Burne-Taney M, Racusen L, Rabb H. Yokota N, et al. Am J Physiol Renal Physiol. 2003 Aug;285(2):F319-25. doi: 10.1152/ajprenal.00432.2002. Epub 2003 Apr 22. Am J Physiol Renal Physiol. 2003. PMID: 12709397